Colgate-Palmolive (NYSE:CL) Receives $103.63 Consensus Price Target from Brokerages
Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two analysts that are currently covering the company, Marketbeat Ratings reports.
Colgate-Palmolive Co (CL) Stock Sees Market Value Hit $72.35 billion: What Are the Implications?
Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $88.56 which represents a slight increase of $0.70 or 0.80% from the prior close of $87.86. The stock opened at $87.6 and touched a low of $87.
RBC Capital Sticks to Its Hold Rating for Colgate-Palmolive (CL)
In a report released on January 15, Nik Modi from RBC Capital maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a
Stifel cuts Colgate-Palmolive stock target to $95, holds rating
Stifel highlighted that Colgate's Hill's pet nutrition brand continues to be a strong growth driver for the company. In the fourth quarter of 2024, Hill's achieved a remarkable 25% growth, with the two-year CAGR also showing acceleration.
What’s Causing Colgate-Palmolive Co (CL) Stock’s -11.66% Drop Over the Last Six Months?
Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $86.36 which represents a decrease of $-1.10 or -1.26% from the prior close of $87.46. The stock opened at $86.51 and touched a low of $85.
Colgate-Palmolive (CL) Receives a Hold from Stifel Nicolaus
Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of
Hosted on MSN1d
Colgate Advances 13% in a Year: To Buy or Not to Buy the Stock?
Colgate-Palmolive Company CL shares have appreciated 13.1% in the trailing 12 months, outperforming the Zacks Consumer ...
Better Pick CL Stock Or KMB Stock?
There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...
Crest, Colgate Lawsuits Target Fluoride in Kids' Toothpaste, Mouth Rinse
(Reuters) - Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of ...
Pallas Capital Advisors LLC Cuts Stake in Colgate-Palmolive (NYSE:CL)
Pallas Capital Advisors LLC lowered its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6.6% in the 4th quarter, ...
Colgate-Palmolive Co. stock outperforms competitors on strong trading day
Colgate-Palmolive Co. closed $22.20 short of its 52-week high ($109.30), which the company reached on September 5th.
Is Colgate-Palmolive Company (NYSE:CL) Trading At A 42% Discount?
Colgate-Palmolive's US$88.56 share price signals that it might be 42% undervalued Analyst price target for CL is US$102 which is 34% below our fair value estimate ...